Open access · US-GOV
via ClinicalTrials.gov Clinical trial
Derivation of Induced Pluripotent Stem Cells from Somatic Cells Donated by Patients with Neurological Diseases for the Study of the Pathogenesis of the Disorders and Development of Novel Therapies
Authors not listed
Hadassah Medical Organization · 2009
Abstract
Human fibroblasts and possibly other human somatic cells may be reprogrammed into induced pluripotent stem (iPS) cells by the forced expression of transcription factors (1-5). The iPS cells seem to share many properties with human embryonic stem cells.
Induced pluripotent stem cells potentially may be useful in the future as an unlimited source of cells for transplantation.
The major goal of the project is to develop human iPS cells from cell cultures from skin biopsies or the patient's hair. The iPS cells will be developed primarily for modeling diseases and drug discovery as well as basic research, and for developing the technology that may eventually allow the use of iPS cells for future transplantation therapy. The iPS cells developed in the course of this application are not intended for use in transplantation therapy. Future development of iPS cells for clinical transplantation therapies will be subjected to the appropriate authorization by ethical and regulatory committees.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- ClinicalTrials.gov
- Canonical
- link ↗
- Fetched
- 2026-11-12 MST
Cite this
APA
Anonymous. (2009). Derivation of Induced Pluripotent Stem Cells from Somatic Cells Donated by Patients with Neurological Diseases for the Study of the Pathogenesis of the Disorders and Development of Novel Therapies. <em>Hadassah Medical Organization</em>. https://clinicaltrials.gov/study/NCT00874783
Vancouver
Anonymous. Derivation of Induced Pluripotent Stem Cells from Somatic Cells Donated by Patients with Neurological Diseases for the Study of the Pathogenesis of the Disorders and Development of Novel Therapies. Hadassah Medical Organization. 2009.
BibTeX
@misc{anon2009Deriva,
title = {Derivation of Induced Pluripotent Stem Cells from Somatic Cells Donated by Patients with Neurological Diseases for the Study of the Pathogenesis of the Disorders and Development of Novel Therapies},
author = {Anonymous},
journal = {Hadassah Medical Organization},
year = {2009},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Bioscience Reports 2018
Open access · CC-BY
Chemical compound-based direct reprogramming for future clinical applications
Blood Cancer Journal 2014
Open access · CC-BY
Induced pluripotent stem cells in hematology: current and future applications
Nature 2012
Preprint · OA
Increased proteasome activity in human embryonic stem cells is regulated by PSMD11
Biochemistry 2023
Open access · CC-BY
Induced Pluripotent Stem Cells: Advances and Applications in Regenerative Medicine
Cells 2017
Open access · CC-BY
Application of Induced Pluripotent Stem Cell Technology to the Study of Hematological Diseases
Elsevier eBooks 2020
Citation only